Barclays analyst Tim Long maintains Casa Systems (NASDAQ:CASA) with a Equal-Weight and raises the price target from $2.5 to $3.
Amneal Pharmaceuticals Reaffirms FY23 Revenue $2.25B-$2.35B, Adj EPS $0.40-$0.50
The Company is affirming its full year 2023 financial guidance previously provided on March 2, 2023.
Full Year 2023 Guidance
Net revenue
$2.25